The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

Share Price Information for 1Spatial Holdings (SPA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.00
Bid: 71.00
Ask: 75.00
Change: 0.00 (0.00%)
Spread: 4.00 (5.634%)
Open: 73.00
High: 73.00
Low: 73.00
Prev. Close: 73.00
SPA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Avisen plc) - Amendment

13 Oct 2011 10:21

RNS Number : 1181Q
Avisen PLC
13 October 2011
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

AVISEN PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

AVISEN PLC

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEROR

(e) Date position held:

13 OCTOBER 2011

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

4P ORDINARY SHARES

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Derivatives (other than options):

0

0

0

0

(3) Options and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

NONE

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

 

Name

Number of Avisen Plc Shares

Approximate % of issued Avisen Plc Share Capital

Marcus Hanke1

29,026,314

12.80%

Marcus Yeoman1

1,581,572

0.70%

Claire Milverton

385,729

0.17%

Mark Battles

17,500

0.01%

Jonathan Hill1,2

4,470,456

1.97%

Avisen plc

3,500,000

1.54%

 

1 Marcus Hanke, Marcus Yeoman and Jonathan Hill hold warrants to subscribe for up to 262,292, 163,932 and 65,572 ordinary shares respectively with an exercise price of 15.25p at any time on or before 17 July 2012.

 

2 Jonathan Hill holds options to subscribe for up to 2,181,818 ordinary shares with an exercise price of 5.5p at any time on or before 11 November 2019.

 

Strand Hanson Limited, holds warrants to subscribe for up to 2,252,692 ordinary shares with an exercise price of 5.09p at any time on or before 29 July 2015.

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

13 OCTOBER 2011

Contact name:

Andrew Emmott

Telephone number:

020 7409 3494

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEMMMMGLFNGMZG
Date   Source Headline
23rd Aug 20182:48 pmRNSHolding(s) in Company
20th Aug 20183:19 pmRNSResult of General Meeting
31st Jul 20187:00 amRNSPosting of Circular & Related Party Transactions
26th Jul 20185:12 pmRNSResult of Placing
26th Jul 201811:06 amRNSClose of Accelerated Bookbuild
26th Jul 20187:00 amRNSLaunch Of Placing Via Accelerated Bookbuild
24th Jul 20181:00 pmRNSResult of AGM
10th Jul 20187:00 amRNSDirector Appointment
2nd Jul 20187:00 amRNSReport and Accounts and Notice of AGM
22nd May 20187:00 amRNSFinal results for the year ended 31 January 2018
9th May 20187:00 amRNSNotice of Results
3rd Apr 20187:00 amRNS1Spatial Awarded Significant Contract
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSTrading Update
15th Mar 20187:00 amRNSDisposal of Enables IT
11th Jan 20184:00 pmRNSHolding(s) in Company
10th Jan 20183:24 pmRNSHolding(s) in Company
9th Jan 20187:00 amRNS1Spatial Awarded US State Contract
4th Dec 20179:30 amRNSHolding(s) in Company
29th Nov 20176:23 pmRNSReplacement: Holding(s) in Company
29th Nov 201712:00 pmRNSHolding(s) in Company
24th Oct 201712:45 pmRNSHolding(s) in Company
10th Oct 20177:01 amRNSInterim Results
10th Oct 20177:00 amRNSDirectorate Changes
19th Sep 201711:24 amRNSHolding(s) in Company
14th Sep 20171:54 pmRNSNotice of Interim Results
14th Sep 20179:58 amEQSEdison Investment Research Limited: Edison issues outlook on 1Spatial (SPA)
14th Sep 20177:00 amRNSUS Contract Wins
11th Sep 20177:00 amRNSContract Win with Northern Gas Networks Ltd
15th Aug 20177:00 amRNSChange of Registered Office
4th Aug 20177:00 amRNSDirector Appointment
27th Jul 20171:19 pmRNSResult of AGM
4th Jul 20177:00 amRNSReport and Accounts and Notice of AGM
23rd May 20177:00 amRNSFinal results for the year ended 31 January 2017
18th Apr 20175:40 pmRNSHolding(s) in Company
11th Apr 20177:00 amRNSShares Acquisition and Notice of Results
27th Mar 20171:13 pmRNSHolding(s) in Company
23rd Mar 20175:50 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSDirector Shareholdings
17th Mar 20179:13 amRNSDirector Shareholdings
15th Mar 20177:00 amRNSDirector Appointment
7th Mar 20177:00 amRNSCompany Update
31st Jan 201711:21 amRNSDirectorate Change
11th Jan 20175:46 pmRNSDirectorate Change
30th Dec 20164:43 pmRNSDirectorate Change
20th Dec 20167:00 amRNSTrading Update and Divestment
24th Nov 20165:23 pmRNSHolding(s) in Company
18th Oct 20167:00 amRNSInterim Results
11th Oct 20167:00 amRNSHERE Reseller Agreement
20th Sep 20169:40 amRNSChairman Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.